Cargando…
A Single Center Experience of Super-Responders Among Severe Asthma Patients Receiving Treatment with Mepolizumab
OBJECTIVE: Anecdotal reports among clinicians treating severe asthma patients with novel add-on treatments such as mepolizumab suggest that a fraction of these patients may experience a much more dramatic benefit from these agents than reported in large, randomized controlled studies. Although these...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Turkish Thoracic Society
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524494/ https://www.ncbi.nlm.nih.gov/pubmed/35957566 http://dx.doi.org/10.5152/TurkThoracJ.2022.22023 |